Bolt Biotherapeutics Inc
BOLT
NASDAQ
Biotechnology
$3.35
USD
+0.14 (+4.36%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $6.18M
Volume 16.0K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
FBLG | Fibrobiologics Inc | $7.66M | - | - | - | |
XBIO | Xenetic Biosciences Inc | $7.56M | - | +23.5% | - | |
ERNA | Ernexa Therapeutics Inc | $7.22M | - | - | +0.3% | |
ALZN | Alzamend Neuro Inc | $7.00M | - | - | - | |
ACXP | Acurx Pharmaceuticals Inc | $6.36M | - | - | - | |
DRMA | Dermata Therapeutics Inc | $6.31M | - | - | - | |
BOLT | Bolt Biotherapeutics Inc | $6.18M | - | +78.6% | - | |
CDIO | Cardio Diagnostics Holdings Inc | $5.95M | - | -16.7% | - | |
PMCB | PharmaCyte Biotech Inc | $5.90M | - | - | - | |
BRTX | BioRestorative Therapies Inc | $5.61M | - | -8.5% | - | |
ENSC | Ensysce Biosciences Inc | $5.23M | - | -24.4% | - |
Top Peer by Growth
Bolt Biotherapeutics Inc
+78.6% YoY Revenue
Best 1-Year Return
Xenetic Biosciences Inc
+10.0% Return